TITLE

Airways in cystic fibrosis are acidified: detection by exhaled breath condensate

AUTHOR(S)
Tate, S.; MacGregor, G.; Davis, M.; Innes, J.A.; Greening, A.P.
PUB. DATE
November 2002
SOURCE
Thorax;Nov2002, Vol. 57 Issue 11, p926
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports that airways in cystic fibrosis are acidified. Detection by exhaled breath condensate; Underlying process in airway acidification; Role of epithelial lining fluid in cystic fibrosis lung disease.
ACCESSION #
9844863

 

Related Articles

  • Early airway infection, inflammation, and lung function in cystic fibrosis. Nixon, G.M.; Armstrong, D.S.; Carzino, R.; Carlin, J.B.; Olinsky, A.; Robertson, C.F.; Grimwood, K. // Archives of Disease in Childhood;Oct2002, Vol. 87 Issue 4, p306 

    Aims: To determine the relation between lower airway infection and inflammation, respiratory symptoms, and lung function in infants and young children with cystic fibrosis (CF). Methods: A prospective study of children with CF aged younger than 3 years, diagnosed by a newborn screening...

  • Normal Breathing Regulates Mucus Clearance in Cystic Fibrosis.  // Pulmonary Reviews;May2007, Vol. 12 Issue 5, p14 

    The article discusses research being done on cystic fibrosis. It references a study by Brian Button et al published in the April 2007 issue of the "Journal of Physiology." Researchers found that the rhythmic motion of the lung during normal breathing can regulate mucus clearance and can help the...

  • NHERF1 and CFTR restore tight junction organisation and function in cystic fibrosis airway epithelial cells: role of ezrin and the RhoA/ROCK pathway. Castellani, Stefano; Guerra, Lorenzo; Favia, Maria; Gioia, Sante Di; Casavola, Valeria; Conese, Massimo // Laboratory Investigation (00236837);Nov2012, Vol. 92 Issue 11, p1527 

    Tight junctions (TJs) restrict the transit of ions and molecules through the paracellular route and act as a barrier to regulate access of inflammatory cells into the airway lumen. The pathophysiology of cystic fibrosis (CF) lung disease is characterised by abnormal ion and fluid transport...

  • Microbiology of airway disease in a cohort of patients with Cystic Fibrosis. Lambiase, Antonietta; Raia, Valeria; Del Pezzo, Mariassunta; Sepe, Angela; Carnovale, Vincenzo; Rossano, Fabio // BMC Infectious Diseases;2006, Vol. 6 Issue 1, p4 

    Background: Recent reports document an increasing incidence of new Gram-negative pathogens such as Stenotrophomonas maltophilia and Alcaligenes xylosoxidans isolated from patients with Cystic Fibrosis, along with an increase in common Gram-negative pathogens such as Pseudomonas aeruginosa and...

  • Impaired cardiac and peripheral hemodynamic responses to inhaled β2-agonist in cystic fibrosis. Van Iterson, Erik H.; Karpen, Stephen R.; Baker, Sarah E.; Wheatley, Courtney M.; Morgan, Wayne J.; Snyder, Eric M. // Respiratory Research;9/5/2015, Vol. 16 Issue 1, p1 

    Background: Pulmonary system dysfunction is a hallmark of cystic fibrosis (CF) disease. In addition to impaired cystic fibrosis transmembrane conductance regulator protein, dysfunctional β2-adrenergic receptors (β2AR) contribute to low airway function in CF. Recent observations suggest CF...

  • Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study. Baumann, Ulrich; Göcke, Kerstin; Gewecke, Britta; Freihorst, Joachim; Von Specht, Bernd Ulrich // Respiratory Research;2007, Vol. 8, p1 

    Background: Vaccination against Pseudomonas aeruginosa is a desirable albeit challenging strategy for prevention of airway infection in patients with cystic fibrosis. We assessed the immunogenicity of a nasal vaccine based on the outer membrane proteins F and I from Pseudomonas aeruginosa in the...

  • New insights into pulmonary inflammation in cystic fibrosis. Rao, S.; Grigg, J. // Archives of Disease in Childhood;Sep2006, Vol. 91 Issue 9, p786 

    Persistent lower airway infection with inflammation is the major cause of morbidity and mortality in cystic fibrosis. This review examines the recent advances in the understanding of airway inflammation in cystic fibrosis, and focuses on the evidence that pulmonary inflammation is, under some...

  • Physiologic Evidence for the Efficacy of Positive Expiratory Pressure as an Airway Clearance Technique in Patients With Cystic Fibrosis. Darbee, Joan C.; Ohtake, Patricia J.; Grant, Brydon JB; Cerny, Frank J. // Physical Therapy;Jun2004, Vol. 84 Issue 6, p524 

    Background and Purpose. Individuals with cystic fibrosis (CF) have large amounts of infected mucus in their lungs, which causes irreversible lung tissue damage. Although patient-administered positive expiratory pressure (PEP) breathing has been promoted as an effective therapeutic modality for...

  • Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Pezzulo, Alejandro A.; Tang, Xiao Xiao; Hoegger, Mark J.; Abou Alaiwa, Mahmoud H.; Ramachandran, Shyam; Moninger, Thomas O.; Karp, Phillip H.; Wohlford-Lenane, Christine L.; Haagsman, Henk P.; van Eijk, Martin; Bánfi, Botond; Horswill, Alexander R.; Stoltz, David A.; McCray, Paul B.; Welsh, Michael J.; Zabner, Joseph // Nature;7/5/2012, Vol. 487 Issue 7405, p109 

    Cystic fibrosis (CF) is a life-shortening disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Although bacterial lung infection and the resulting inflammation cause most of the morbidity and mortality, how the loss of CFTR function first disrupts...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics